CuraScript's Management Buyout

CuraScript raised a round of funding on June 12, 2000. Investors include GTCR.

CuraScript operates six specialty pharmacies throughout the United States. CuraScript has a broad product offering, with strong capabilities in oncology, rheumatoid arthritis, multiple sclerosis and o…

Articles about CuraScript's Management Buyout: